Integral Ad Science (NASDAQ:IAS) versus Haoxi Health Technology (NASDAQ:HAO) Critical Contrast

Integral Ad Science (NASDAQ:IAS) and Haoxi Health Technology (NASDAQ:HAO) are both small-cap communication services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Insider & Institutional Ownership

95.8% of Integral Ad Science shares are held by institutional investors. 2.0% of Integral Ad Science shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Integral Ad Science and Haoxi Health Technology’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Integral Ad Science	0.57%	0.31%	0.25%
Haoxi Health Technology	N/A	N/A	N/A

Analyst Ratings

This is a summary of current recommendations for Integral Ad Science and Haoxi Health Technology, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integral Ad Science	0	3	8	0	2.73
Haoxi Health Technology	0	0	0	0	N/A

Integral Ad Science presently has a consensus target price of $16.40, suggesting a potential upside of 52.13%. Given Integral Ad Science’s higher probable upside, equities research analysts clearly believe Integral Ad Science is more favorable than Haoxi Health Technology.

Earnings & Valuation

This table compares Integral Ad Science and Haoxi Health Technology”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integral Ad Science	$498.16 million	3.47	$7.24 million	$0.01	1,078.00
Haoxi Health Technology	$42.57 million	0.07	N/A	N/A	N/A

Integral Ad Science has higher revenue and earnings than Haoxi Health Technology.

Summary

Integral Ad Science beats Haoxi Health Technology on 9 of the 9 factors compared between the two stocks.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video. Its digital media quality solutions offer ad fraud detection and prevention, viewability, brand safety and suitability, contextual targeting, inventory yield management, and reporting. In addition, the company offers Quality Impressions, a metric designed to verify that digital ads are served to a real person rather than a bot, viewable on-screen, and presented in a brand-safe and suitable environment in the correct geography; Context Control solution that delivers contextual targeting and brand suitability capabilities; pre-bid programmatic and post-bid verification solutions for advertisers; and optimization and verification solutions for publishers. It serves advertisers and agencies, publishers, and supply side platforms. The company was founded in 2009 and is headquartered in New York, New York.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.